mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.03 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.04 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.04 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.04 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.04 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.04 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.04 |